ICP-MS analysis of lanthanide-doped nanoparticles as a non-radiative, multiplex approach to quantify biodistribution and blood clearance

Biomaterials

Volumn 33, Issue 5, 2012, Pages 1509-1519

  Crayton, Samuel H ^a   Elias, Drew R ^a   Al Zaki, Ajlan ^a   Cheng, Zhiliang ^a   Tsourkas, Andrew ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Biodistribution; Clearance; ICP MS; Multiplex; Nanoparticle; Superparamagnetic iron oxide; XPS

Indexed keywords

BIODISTRIBUTIONS; CLEARANCE; ICP-MS; MULTIPLEX; SUPERPARAMAGNETIC IRON OXIDES;

BLOOD; CHEMICAL ANALYSIS; DENDRIMERS; DOPING (ADDITIVES); INDUCTIVELY COUPLED PLASMA; IRON OXIDES; LIPOSOMES; MASS SPECTROMETERS; MASS SPECTROMETRY; MULTIPLEXING; PHOSPHOLIPIDS; RARE EARTH ELEMENTS; SUPERPARAMAGNETISM; SURFACE CHEMISTRY; TUMORS; X RAY PHOTOELECTRON SPECTROSCOPY;

NANOPARTICLES;

DENDRIMER; LANTHANIDE; LIPOSOME; POLYMER; SUPERPARAMAGNETIC IRON OXIDE; TRACER;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD ANALYSIS; CANCER SURGERY; CYTOTOXICITY; ENCAPSULATION; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TUMOR LOCALIZATION;

ANIMALS; DEXTRANS; LANTHANOID SERIES ELEMENTS; LIGHT; MAGNETITE NANOPARTICLES; MICE; NANOPARTICLES; NIH 3T3 CELLS; PARTICLE SIZE; REPRODUCIBILITY OF RESULTS; SCATTERING, RADIATION; SPECTROMETRY, X-RAY EMISSION; SPECTROPHOTOMETRY, ATOMIC; STATIC ELECTRICITY; SURFACE PROPERTIES; TISSUE DISTRIBUTION;

MUS;

EID: 83355166274     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.10.077     Document Type: Article

References (32)

1. Matson M.L., Wilson L.J. Nanotechnology and MRI contrast enhancement. Future Med Chem 2010, 2:491-502.
2. Solomon M., D'Souza G.G. Recent progress in the therapeutic applications of nanotechnology. Curr Opin Pediatr 2011, 23:215-220.
3. Tan S.J., Kiatwuthinon P., Roh Y.H., Kahn J.S., Luo D. Engineering nanocarriers for siRNA delivery. Small 2011, 7:841-856.
4. Crayton S.H., Chen A.K., Cheng Z., Tsourkas A. Molecular imaging. Comprehensive biomaterials 2011, Elsevier. P. Ducheyne, K. Healy, D. Hutmacher, J. Kirkpatrick (Eds.).
5. Thorek D.L., Chen A.K., Czupryna J., Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 2006, 34:23-38.
6. Muzykantov V.R., Puchnina E.A., Atochina E.N., Hiemish H., Slinkin M.A., Meertsuk F.E., et al. Endotoxin reduces specific pulmonary uptake of radiolabeled monoclonal antibody to angiotensin-converting enzyme. J Nucl Med 1991, 32:453-460.
7. Cahouet A., Denizot B., Hindre F., Passirani C., Heurtault B., Moreau M., et al. Biodistribution of dual radiolabeled lipidic nanocapsules in the rat using scintigraphy and gamma counting. Int J Pharm 2002, 242:367-371.
8. Thorek D.L., Tsourkas A. Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials 2008, 29:3583-3590.
9. Moore A., Josephson L., Bhorade R.M., Basilion J.P., Weissleder R. Human transferrin receptor gene as a marker gene for MR imaging. Radiology 2001, 221:244-250.
10. Turkevich J., Stevenson P.C., Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc 1951, 11:55-75.
11. Karmali P.P., Simberg D. Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems. Expert Opin Drug Deliv 2011, 8:343-357.
12. Moghimi S.M., Davis S.S. Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection. Crit Rev Ther Drug Carrier Syst 1994, 11:31-59.
13. Moghimi S.M., Hunter A.C., Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001, 53:283-318.
14. Chouly C., Pouliquen D., Lucet I., Jeune J.J., Jallet P. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. J Microencapsul 1996, 13:245-255.
15. Enochs W.S., Harsh G., Hochberg F., Weissleder R. Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J Magn Reson Imaging 1999, 9:228-232.
16. Moore A., Marecos E., Bogdanov A., Weissleder R. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 2000, 214:568-574.
17. Zimmer C., Weissleder R., Poss K., Bogdanova A., Wright S.C., Enochs W.S. MR imaging of phagocytosis in experimental gliomas. Radiology 1995, 197:533-538.
18. Zimmer C., Wright S.C., Engelhardt R.T., Johnson G.A., Kramm C., Breakefield X.O., et al. Tumor cell endocytosis imaging facilitates delineation of the glioma-brain interface. Exp Neurol 1997, 143:61-69.
19. McNeil S.E. Nanotechnology for the biologist. J Leukoc Biol 2005, 78:585-594.
20. Perrault S.D., Walkey C., Jennings T., Fischer H.C., Chan W.C. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett 2009, 9:1909-1915.
21. Kobayashi H., Kawamoto S., Jo S.K., Bryant H.L., Brechbiel M.W., Star R.A. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. Bioconjug Chem 2003, 14:388-394.
22. Sato N., Kobayashi H., Hiraga A., Saga T., Togashi K., Konishi J., et al. Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores. Magn Reson Med 2001, 46:1169-1173.
23. Jokerst J.V., Lobovkina T., Zare R.N., Gambhir S.S. Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond) 2011, 6:715-728.
24. De Jong W.H., Hagens W.I., Krystek P., Burger M.C., Sips A.J., Geertsma R.E. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008, 29:1912-1919.
25. Poznansky M.J., Juliano R.L. Biological approaches to the controlled delivery of drugs: a critical review. Pharmacol Rev 1984, 36:277-336.
26. Tomalia D.A., Reyna L.A., Svenson S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem Soc Trans 2007, 35:61-67.
27. Aggarwal P., Hall J.B., McLeland C.B., Dobrovolskaia M.A., McNeil S.E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 2009, 61:428-437.
28. Huang R.B., Mocherla S., Heslinga M.J., Charoenphol P., Eniola-Adefeso O. Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery. Mol Membr Biol 2010, 27:312-327.
29. Hsieh Y.K., Jiang P.S., Yang B.S., Sun T.Y., Peng H.H., Wang C.F. Using laser ablation/inductively coupled plasma mass spectrometry to bioimage multiple elements in mouse tumors after hyperthermia. Anal Bioanal Chem 2011, 401:909-915.
30. Koch J., Gunther D. Review of the state-of-the-art of laser ablation inductively coupled plasma mass spectrometry. Appl Spectrosc 2011, 65:155-162.
31. Jain K.K. Advances in the field of nanooncology. BMC Med 2010, 8:83.
32. Stark W.J. Nanoparticles in biological systems. Angew Chem Int Ed Engl 2011, 50:1242-1258.